As of Aug 28
| +0.25 / +3.33%|
The 6 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 13.50, with a high estimate of 20.00 and a low estimate of 7.00. The median estimate represents a +73.97% increase from the last price of 7.76.
The current consensus among 7 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.